Evaluation of the practicability of biosynex antigen self-test covid-19 ag+ for the detection of sars-cov-2 nucleocapsid protein from self-collected nasal mid-turbinate secretions in the general public in france

Tonen-Wolyec, S.; Dupont, R.; Awaida, N.; Batina-Agasa, S.; Hayette, Marie-Pierre; Bélec, L.

doi:10.3390/diagnostics11122217

Article (Scientific journals)

Evaluation of the practicability of biosynex antigen self-test covid-19 ag+ for the detection of sars-cov-2 nucleocapsid protein from self-collected nasal mid-turbinate secretions in the general public in france

Tonen-Wolyec, S.; Dupont, R.; Awaida, N. et al.

2021 • In Diagnostics, 11 (12)

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/295899

DOI
10.3390/diagnostics11122217

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

2.pdf

Author postprint (1.82 MB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Antigen; COVID-19; France; General public; N nucleocapsid protein; Nasal mid-turbinate secretions; Rapid diagnostic test; SARS-CoV-2; Self-test; coronavirus nucleocapsid protein; virus antigen; adult; antigen detection; Article; clinical trial; controlled study; coronavirus disease 2019; COVID-19 nucleic acid testing; COVID-19 testing; diagnostic accuracy; diagnostic test accuracy study; female; human; human tissue; lateral flow immunochromatography; major clinical study; male; mid-turbinate swab; multiplex real time polymerase chain reaction; nasopharyngeal swab; nonhuman; nose secretion; prospective study; real time reverse transcription polymerase chain reaction; reliability; satisfaction; self-testing; sensitivity and specificity; Severe acute respiratory syndrome coronavirus 2; turbinate; usability; volunteer; Youden index; young adult

Abstract :

[en] Due to their ease-of-use, lateral flow assay SARS-CoV-2 antigen-detecting rapid diagnostic tests could be suitable candidates for antigen-detecting rapid diagnostic self-test (Ag-RDST). We evaluated the practicability of the Ag-RDST BIOSYNEX Antigen Self-Test COVID-19 Ag+ (Biosynex Swiss SA, Freiburg, Switzerland), using self-collected nasal secretions from the turbinate medium (NMT), in 106 prospectively included adult volunteers living in Paris, France. The majority of the participants correctly understood the instructions for use (94.4%; 95% confidence interval (CI): 88.3– 97.4), showing a great ability to perform the entire self-test procedure to obtain a valid and interpretable result (100%; 95% CI: 96.5–100), and demonstrated the ability to correctly interpret test results (96.2%; 95% CI: 94.2–97.5) with a high level of general satisfaction. About one in eight participants (# 15%) needed verbal help to perform or interpret the test, and only 3.8% of test results were misinterpreted. By reference to multiplex real-time RT-PCR, the Ag-RDST showed 90.9% and 100% sensitivity and specificity, respectively, and high agreement (98.1%), reliability (0.94), and accuracy (90.9%) to detect SARS-CoV-2 antigen. Taken together, our study demonstrates the high usability and accuracy of BIOSYNEX Antigen Self-Test COVID-19 Ag+ for supervised self-collected NMT sampling in an unselected adult population living in France. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Disciplines :

Laboratory medicine & medical technology

Author, co-author :

Tonen-Wolyec, S.; Ecole Doctorale Régionale D’Afrique Centrale en Infectiologie Tropicale, Franceville, 876, Gabon, Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, 2012, Congo

Dupont, R.; Laboratoire Paris XV, Paris, 75015, France

Awaida, N.; Laboratoire Paris XV, Paris, 75015, France

Batina-Agasa, S.; Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, 2012, Congo

Hayette, Marie-Pierre ; Centre Hospitalier Universitaire de Liège - CHU > > Service de microbiologie clinique

Bélec, L.; Laboratoire de Virologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, and Université of Paris, Sorbonne Paris Cité, Paris, 75015, France

Language :

English

Title :

Publication date :

2021

Journal title :

Diagnostics

eISSN :

2075-4418

Publisher :

MDPI

Volume :

Issue :

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 21 October 2022

Statistics

Number of views

84 (0 by ULiège)

Number of downloads

61 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Hardan, L.; Filtchev, D.; Kassem, R.; Bourgi, R.; Lukomska-Szymanska, M.; Tarhini, H.; Salloum-Yared, F.D.; Mancino, D.; Kharouf, N.; Haikel, Y. COVID-19 and Alzheimer’s Disease: A Literature Review. Medicina 2021, 57, 1159.
Grassly, N.C.; Pons-Salort, M.; Parker, E.P.K.; White, P.J.; Ferguson, N.M.; Imperial College COVID-19 Response Team. Comparison of molecular testing strategies for COVID-19 control: A mathematical modelling study. Lancet Infect. Dis. 2020, 20, 1381– 1389.
Paltiel, A.D.; Zheng, A.; Walensky, R.P. Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States. JAMA Netw. Open 2020, 3, e2016818.
Smithgall, M.C.; Dowlatshahi, M.; Spitalnik, S.L.; Hod, E.A.; Rai, A.J. Types of Assays for SARS-CoV-2 Testing: A Review. Lab. Med. 2020, 51, e59–e65.
Rai, P.; Kumar, B.K.; Deekshit, V.K.; Karunasagar, I.; Karunasagar, I. Detection technologies and recent developments in the diagnosis of COVID-19 infection. Appl. Microbiol. Biotechnol. 2021, 105, 441–455.
Dinnes, J.; Deeks, J.J.; Adriano, A.; Berhane, S.; Davenport, C.; Dittrich, S.; Emperador, D.; Takwoingi, Y.; Cunningham, J.; Beese, S.; et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst. Rev. 2020, 8, CD013705.
Li, D.; Li, J. Immunologic testing for SARS-CoV-2 infection from the antigen perspective. J. Clin. Microbiol. 2020, 59, e02160-20.
European Centre for Disease Prevention and Control. Options for the Use of Rapid Antigen Tests for COVID-19 in the EU/EEA and the UK. 19 November 2020. Available online: https://www.ecdc.europa.eu/en/publications-data/options-use-rapid-antigen-tests-covid-19-eueea-and-uk (accessed on 31 May 2021).
Toptan, T.; Eckermann, L.; Pfeiffer, A.E.; Hoehl, S.; Ciesek, S.; Drosten, C.; Corman, V.M. Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread? J. Clin. Virol. 2020, 135, 104713.
Deitmer, T.; Dietz, A.; Chaberny, I.F.; Pietsch, C. [The nasal and pharyngeal swab techniques during the COVID-19-pandemic-the ENT-perspective-SARS-CoV-2, Coronavirus, nasal swab, pharyngeal swab, complications]. Laryngo-Rhino-Otologie 2021, 100, 517–525.
Centers for Disease Control and Prevention (CDC). Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19. Updated 26 February 2021. Available online: https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clini-cal-specimens.html (accessed on 31 May 2021).
Lindner, A.K.; Nikolai, O.; Kausch, F.; Wintel, M.; Hommes, F.; Gertler, M.; Krüger, L.J.; Gaeddert, M.; Tobian, F.; Lainati, F.; et al. Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected nasal swab versus professional-collected nasopharyngeal swab. Eur. Respir J. 2021, 57, 2003961.
Nikolai, O.; Rohardt, C.; Tobian, F.; Junge, A.; Corman, V.M.; Jones, T.C.; Gaeddert, M.; Lainati, F.; Sacks, J.A.; Seybold, J.; et al. Anterior nasal versus nasal mid-turbinate sampling for a SARS-CoV-2 antigen-detecting rapid test: Does localisation or professional collection matter? MedRxiv 2021. https://doi.org/10.1101/2021.02.09.21251274.
Klein, J.A.F.; Krüger, L.J.; Tobian, F.; Gaeddert, M.; Lainati, F.; Schnitzler, P.; Lindner, A.K.; Nikolai, O.; Knorr, B.; Welker, A.; et al. Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test. Med. Microbiol. Immunol. 2021, 210, 181–186.
Krüger, L.J.; Klein, J.A.F.; Tobian, F.; Gaeddert, M.; Lainati, F.; Klemm, S.; Schnitzler, P.; Bartenschlager, R.; Cerikan, B.; et al.; ACE-IT Study Group. Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detect-ing point-of-care device for SARS-CoV-2. Infection. 2021, Aug 12, 1-12.
Liao, W.T.; Hsu, M.Y.; Shen, C.F.; Hung, K.F.; Cheng, C.M. Home Sample Self-Collection for COVID-19 Patients. Adv. Biosyst. 2020, 4, e2000150.
Boum, Y.; Eyangoh, S.; Okomo, M.C. Beyond COVID-19-will self-sampling and testing become the norm? Lancet Infect. Dis. 2021, 21, 1194–1195, https://doi.org/10.1016/S1473-3099(21)00197-3.
Larremore, D.B.; Wilder, B.; Lester, E.; Shehata, S.; Burke, J.M.; Hay, J.A.; Tambe, M.; Mina, M.J.; Parker, R. Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening. Sci. Adv. 2020, 7, eabd5393.
Mercer, T.R.; Salit, M. Testing at scale during the COVID-19 pandemic. Nat. Rev. Genet. 2021, 22, 415–426.
Peacock, F.W.; Dzieciatkowski, T.; Chirico, F.; Szarpak, L. Self-testing with antigen tests as a method for reduction SARS-CoV-2. Am. J. Emerg. Med. 2021, S0735-6757(21)00385-5. doi: 10.1016/j.ajem.2021.05.010.
Goggolidou, P.; Hodges-Mameletzis, I.; Purewal, S.; Karakoula, A.; Warr, T. Self-Testing as an Invaluable Tool in Fighting the COVID-19 Pandemic. J. Prim. Care Community Health 2021, 12. https://doi.org/10.1177/21501327211047782.
Figueroa, C.; Johnson, C.; Ford, N.; Sands, A.; Dalal, S.; Meurant, R.; Prat, I.; Hatzold, K.; Urassa, W.; Baggaley, R. Reliability of HIV rapid diagnostic tests for self-testing compared with testing by health-care workers: A systematic review and meta-analy-sis. Lancet HIV 2018, 5, e277–e290.
Rivera, A.S.; Hernandez, R.; Mag-Usara, R.; Sy, K.N.; Ulitin, A.R.; O’Dwyer, L.C.; McHugh, M.C.; Jordan, N.; Hirschhorn, L.R. Implementation outcomes of HIV self-testing in low-and middle-income countries: A scoping review. PLoS ONE 2021, 16, e0250434.
FDA News Release. Coronavirus (COVID-19) Update: FDA Issues New Authorization for the BinaxNOW COVID-19 Ag Card Home Test. 16 December 2020. Available online: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-new-authorization-binaxnow-covid-19-ag-card-home-test (accessed on 27 May 2021).
Osmanodja, B.; Budde, K.; Zickler, D.; Naik, M.G.; Hofmann, J.; Gertler, M.; Hülso, C.; Rössig, H.; Horn, P.; Seybold, J.; et al. Accuracy of a Novel SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Test from Standardized Self-Collected Anterior Nasal Swabs. J. Clin. Med. 2021, 10, 2099.
Stohr, J.J.J.M.; Zwart, V.F.; Goderski, G.; Meijer, A.; Nagel-Imming, C.R.S.; Kluytmans-van den Bergh, M.F.Q.; Pas, S.D.; van den Oetelaar, F.; Hellwich, M.; Gan, K.H.; et al. Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community. Clin. Microbiol. Infect. 2021, doi:10.1016/j.cmi.2021.07.039.
World Health Organization (WHO). WHO prequalification: Sample Product Dossier for an IVD Intended for HIV Self-Testing. SIMU™ Self-Test for HIV 12O Working Document, December 2015. Available online: http://www.who.int/sam-ple_dos_self_testinghiv_for_public_c__comment_v1_pdf. 2015 (accessed on 21 May 2021).
Prazuck, T.; Karon, S.; Gubavu, C.; Andre, J.; Legall, J.M.; Bouvet, E.; Kreplak, G.; Teglas, J.P.; Pialoux, G. A finger-stick whole-blood HIV self-test as an HIV screening tool adapted to the general public. PLoS ONE 2016, 11, e0146755.
Tonen-Wolyec, S.; Batina-Agasa, S.; Muwonga, J.; Fwamba N’kulu, F.; Mboumba Bouassa, R.S.; Belec, L. Evaluation of the practicability and virological performance of finger-stick whole-blood HIV self-testing in French-speaking sub-Saharan Africa. PLoS ONE 2018, 13, e0189475.
Tonen-Wolyec, S.; Dupont, R.; Batina-Agasa, S.; Hayette, M.P.; Bélec, L. Capillary whole-blood IgG-IgM COVID-19 self-test as a serological screening tool for SARS-CoV-2 infection adapted to the general public. PLoS ONE 2020, 15, e0240779.
Journal Officiel de la République Française. Arrêté du 16 Octobre 2020 Modifiant l’arrêté du 10 Juillet 2020 Prescrivant les Mesures Générales Nécessaires Pour Faire Face à l’épidémie de Covid-19 Dans les Territoires Sortis de l’état d’urgence Sanitaire et Dans Ceux où il a été Prorogé—Légifrance JORF n°0253 du 17 Octobre 2020. Available online: https://www.legifrance.gouv.fr/eli/arrete/2020/10/16/SSAZ2027698A/jo/article_snum (accessed on 27 May 2021).
Journal Officiel de la République Française. Arrêté du 12 Décembre 2020 Portant Modification des Conditions de Rembourse-ment de l’acte de Détection du Génome du SARS-CoV-2 Par Amplification Génique. Available online: https://www.legifrance.gouv.fr/download/file/MG2FA_IlBEW4Y-eXqzLe7od0-jy1YneS77Jhrh9N7pM=/JOE_TEXTE (accessed on 27 May 2021).
Haute Autorité de Santé, Saint-Denis, France, 6 mars 2020. Avis n°2020.0020/AC/SEAP du 6 Mars 2020 du Collège de la HAS relatif à l’inscription Sur la LAP Mentionnée à l’article L. 162-1-7 du CSS, de la Détection du Génome du Coronavirus SARS-CoV-2 par Technique de Transcription Inverse Suivie d’une Amplification. Available online: https://www.has-sante.fr/jcms/p_3161218/fr/avis-n2020-0020/ac/seap-du-6-mars-2020-du-college-de-la-has-relatif-a-l-inscription-sur-la-lap-mentionnee-a-l-article-l-162-1-7-du-css-de-la-detection-du-genome-du-coronavirus-sars-cov-2-par-technique-de-transcription-inverse-suivie-d-une-amplification (accessed on 27 May 2021).
Newcombe, R.G. Two-sided confidence intervals for the single proportion: Comparison of 362 seven methods. Stat. Med. 1998, 17, 857–872.
Cohen, J. A coefficient of agreement for nominal scales. Educ. Psychol. Meas. 1960, 20, 37–46.
Landlis, J.R.; Koch, G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33, 159–174.
Youden, W.J. Index for rating diagnostic tests. Cancer 1950, 3, 32–35.
Journal Officiel de la République Française. Ordonnance n° 2010-49 du 13 Janvier 2010 Relative à la Biologie Médicale. Available online: https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000021683301/(accessed on 21 January 2021).
Haute Autorité de Santé, Saint-Denis, France, 23 avril 2021. Avis n° 2021.0029/AC/SEAP du 23 Avril 2021 du Collège de la HAS Relatif à la Détection Antigénique Rapide du Virus SARS-CoV-2 sur Prélèvement Nasal (TDR, TROD et Autotest). Available online: https://www.has-sante.fr/jcms/p_3263368/fr/avis-n-2021-0029/ac/seap-du-23-avril-2021-du-college-de-la-has-relatif-a-la-detection-antigenique-rapide-du-virus-sars-cov-2-sur-prelevement-nasal-tdr-trod-et-autotest (accessed on 27 May 2021).
Tonen-Wolyec, S.; Mboup, S.; Grésenguet, G.; Bouassa, R.B.; Bélec, L. Insufficient education is a challenge for HIV self-testing. Lancet HIV 2018, 5, e341.
World Health Organization. Guidelines on HIV Self-Testing and Partner Notification: Supplement to Consolidated Guidelines on HIV Testing Services. December 2016. Available online: http://apps.who.int/iris/bitstream/han-dle/10665/251655/9789241549868-eng.pdf;jsessionid=B043673B59952F021C313F076554ABA6?sequence=1 (accessed on 28 May 2021).
Ortblad, K.F.; Musoke, D.K.; Ngabirano, T.; Nakitende, A.; Haberer, J.E.; McConnell, M.; Salomon, J.A.; Bärnighausen, T.; Ol-denburg, C.E. Female sex workers often incorrectly interpret HIV self-test results in Uganda. J. Acquir. Immune Defic. Syndr. 2018, 79, e42–e45.
Tahlil KM, Ong JJ, Rosenberg NE, Tang W, Conserve DF, Nkengasong S; et al. Verification of HIV Self-Testing Use and Results: A Global Systematic Review. AIDS Patient Care STDS 2020, 34, 147–156.
Larios, O.E.; Coleman, B.L.; Drews, S.J.; Mazzulli, T.; Borgundvaag, B.; Green, K.; STOP-Flu Study Group; McGeer, A.J. Self-collected mid-turbinate swabs for the detection of respiratory viruses in adults with acute respiratory illnesses. PLoS ONE 2011, 6, e21335.
Cockerill, F.R.; Wohlgemuth, J.G.; Radcliff, J.; Sabol, C.E.; Kapoor, H.; Dlott, J.S.; Marlowe, E.M.; Clarke, N.J. Evolution of Specimen Self-Collection in the COVID-19 Era: Implications for Population Health Management of Infectious Disease. Popul. Health Manag. 2021, 24, S26–S34.
Akmatov, M.K.; Gatzemeier, A.; Schughart, K.; Pessler, F. Equivalence of self-and staff-collected nasal swabs for the detection of viral respiratory pathogens. PLoS ONE 2012, 7, e48508.
Dhiman, N.; Miller, R.M.; Finley, J.L. Effectiveness of patient-collected swabs for influenza testing. Mayo Clin. Proc. 2012, 87, 548–554.
Goyal, S.; Prasert, K.; Praphasiri, P. The acceptability and validity of self-collected nasal swabs for detection of influenza virus infection among older adults in Thailand. Influenza Other Respir. Viruses 2017, 11, 412–417.
Jackson, M.L.; Nguyen, M.; Kirlin, B.; Madziwa, L. Self-collected nasal swabs for respiratory virus surveillance. Open Forum Infect. Dis. 2015, 2, ofv152.
Prazuck, T.; Phan Van, J.; Sinturel, F.; Levray, F.; Elie, A.; Camera, D.; Pialoux, G. Evaluation of the practicability of a finger-stick whole-blood SARS-Cov-2 self-test adapted for the general population. PLoS ONE 2021, 16, e0245848.
Zou, L.; Ruan, F.; Huang, M.; Liang, L.; Huang, H.; Hong, Z.; Yu, J.; Kang, M.; Song, Y.; Xia, J.; et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N. Engl. J. Med. 2020, 382, 1177–1179.
World Health Organization. Interim Guidance. Antigen-Detection in the Diagnosis of SARS-CoV-2 Infection Using Rapid Im-mune-Assays. 11 September 2020. Available online: file:///C:/Users/prbel/Downloads/WHO-2019-nCoV-Antigen_Detection-2020.1-eng%20(1).pdf (accessed on 31 May 2021).
Cerutti, F.; Burdino, E.; Milia, M.G.; Allice, T.; Gregori, G.; Bruzzone, B.; Ghisetti, V. Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2. J. Clin. Virol. 2020, 132,104654.
Chaimayo, C.; Kaewnaphan, B.; Tanlieng, N.; Athipanyasilp, N.; Sirijatuphat, R.; Chayakulkeeree, M.; Angkasekwinai, N.; Sut-thent, R.; Puangpunngam, N.; Tharmviboonsri, T.; et al. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand. Virol. J. 2020, 17, 177.
Diao, B.; Wen, K.; Zhang, J.; Chen, J.; Han, C.; Chen, Y.; Wang, S.; Deng, G.; Zhou, H.; Wu, Y. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection. Clin. Microbiol. Infect. 2020, 27, 289-e1.
Linares, M.; Pérez-Tanoira, R.; Carrero, A.; Romanyk, J.; Pérez-García, F.; Gómez-Herruz, P.; Arroyo, T.; Cuadros, J. Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms. J. Clin. Virol. 2020, 133, 104659.
Weitzel, T.; Legarraga, P.; Iruretagoyena, M.; Pizarro, G.; Vollrath, V.; Araos, R.; Munita, J.M.; Porte, L. Comparative evaluation of four rapid SARS-CoV-2 antigen detection tests using universal transport medium. Travel Med. Infect. Dis. 2020, 39, 101942.
Courtellemont, L.; Guinard, J.; Guillaume, C.; Giaché, S.; Rzepecki, V.; Seve, A.; Gubavu, C.; Baud, K.; Le Helloco, C.; Cassuto, G.N.; et al. High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 in-fection. J. Med. Virol. 2021, 93, 3152–3157.
Mboumba Bouassa, R.S.; Veyer, D.; Péré, H.; Bélec, L. Analytical performances of the point-of-care SIENNA™ COVID-19 Antigen Rapid Test for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: A prospective evaluation during the COVID-19 second wave in France. Int. J. Infect. Dis. 2021, 106, 8–12.
Favresse, J.; Gillot, C.; Oliveira, M.; Cadrobbi, J.; Elsen, M.; Eucher, C.; Laffineur, K.; Rosseels, C.; Van Eeckhoudt, S.; Nicolas, J.B.; et al. Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infec-tion. J. Clin. Med. 2021, 10, E265.
Schildgen, V.; Demuth, S.; Lüsebrink, J.; Schildgen, O. Limits and Opportunities of SARS-CoV-2 Antigen Rapid Tests: An Ex-perienced-Based Perspective. Pathogens 2021, 10, E38.
Albert, E.; Torres, I.; Bueno, F.; Huntley, D.; Molla, E.; Fernández-Fuentes, M.Á.; Martínez, M.; Poujois, S.; Forqué, L.; Valdivia, A.; et al. Field evaluation of a rapid antigen test (Panbio COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres. Clin. Microbiol. Infect. 2021, 27, 472-e7.
Scohy, A.; Anantharajah, A.; Bodéus, M.; Kabamba-Mukadi, B.; Verroken, A.; Rodriguez-Villalobos, H. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J. Clin. Virol. 2020, 129, 104455.
Yamayoshi, S.; Sakai-Tagawa, Y.; Koga, M.; Akasaka, O.; Nakachi, I.; Koh, H.; Maeda, K.; Adachi, E.; Saito, M.; Nagai, H.; et al. Comparison of Rapid Antigen Tests for COVID-19. Viruses 2020, 12, 1420.
Osterman, A.; Baldauf, H.M.; Eletreby, M.; Wettengel, J.M.; Afridi, S.Q.; Fuchs, T.; Holzmann, E.; Maier, A.; Döring, J.; Grzimek-Koschewa, N.; et al. Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting. Med. Microbiol. Immunol. 2021. https://doi.org/10.1007/s00430-020-00698-8.
Haute Autorité de Santé, Saint-Denis, France, 8 octobre 2020. Revue Rapide sur les Tests de Détection Antigénique du Virus SARS-CoV-2. Available online: file:///C:/Users/prbel/Downloads/synthese_tests_antigeniques_vd%20(1).pdf (accessed on 30 May 2021).
Guglielmi, G. Fast coronavirus tests: What they can and can’t do. Nature 2020, 585, 496–498.
Mattiuzzi, C.; Henry, B.; Lippi, G. Making sense of rapid antigen testing in SARS-CoV-2 diagnostics. Diagnosis 2020. doi:10.1515/dx-2020-0131
Mina, M.J.; Parker, R.; Larremore, D.B. Rethinking Covid-19 Test Sensitivity—A Strategy for Containment. N. Engl. J. Med. 2020, 383, e120.
Food and Drug Administration. In Vitro diagnostics EUAs. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2020. Available online: https://www.fda.gov/medical-devices/coronavirusdisease-2019-covid-19-emergency-use-authorizations-medical-devices/vitro-diagnostics-euas (accessed on 30 May 2021).
McCulloch, D.J.; Kim, A.E.; Wilcox, N.C.; Logue, J.K.; Greninger, A.L.; Englund, J.A.; Chu, H.Y. Comparison of Unsupervised Home Self-collected Midnasal Swabs With Clinician-Collected Nasopharyngeal Swabs for Detection of SARS-CoV-2 Infection. JAMA Netw. Open 2020, 3, e2016382.
Tu, Y.P.; Jennings, R.; Hart, B.; Cangelosi, G.A.; Wood, R.C.; Wehber, K.; Verma, P.; Vojta, D.; Berke, E.M. Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing. N. Engl. J. Med. 2020, 383, 494–496.
Wehrhahn, M.C.; Robson, J.; Brown, S.; Bursle, E.; Byrne, S.; New, D.; Chong, S.; Newcombe, J.P.; Siversten, T.; Hadlow, N. Self-collection: An appropriate alternative during the SARS-CoV-2 pandemic. J. Clin. Virol. 2020, 128, 104417.
Kagan, R.M.; Rogers, A.A.; Borillo, G.A.; Clarke, N.J.; Marlowe, E.M. Performance of Unobserved Self-Collected Nasal Swabs for Detection of SARS-CoV-2 by RT-PCR Utilizing a Remote Specimen Collection Strategy. Open Forum Infect. Dis. 2021, 8, ofab039.
Kriegova, E.; Fillerova, R.; Raska, M.; Manakova, J.; Dihel, M.; Janca, O.; Sauer, P.; Klimkova, M.; Strakova, P.; Kvapil, P. Excel-lent option for mass testing during the SARS-CoV-2 pandemic: Painless self-collection and direct RT-qPCR. Virol. J. 2021, 18, 95.
Torretta, S.; Zuccotti, G.; Cristofaro, V.; Ettori, J.; Solimeno, L.; Battilocchi, L.; D’Onghia, A.; Bonsembiante, A.; Pignataro, L.; Marchisio, P.; et al. Diagnosis of SARS-CoV-2 by RT-PCR Using Different Sample Sources: Review of the Literature. Ear Nose Throat J. 2021, 100 (Suppl. 2), 131S–138S.
Tsang, N.N.Y.; So, H.C.; Ng, K.Y.; Cowling, B.J.; Leung, G.M.; Ip, D.K.M. Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: A systematic review and meta-analysis. Lancet Infect. Dis. 2021, 21, 1233–1245, S1473-3099(21)00146-8.
Esposito, S.; Molteni, C.G.; Daleno, C.; Valzano, A.; Tagliabue, C.; Galeone, C.; Milani, G.; Fossali, E.; Marchisio, P.; Principi, N. Collection by trained pediatricians or parents of mid-turbinate nasal flocked swabs for the detection of influenza viruses in childhood. Virol. J. 2010, 7, 85.
Seaman, C.P.; Tran, L.T.T.; Cowling, B.J.; Sullivan, S.G. Self-collected compared with professional-collected swabbing in the diagnosis of influenza in symptomatic individuals: A meta-analysis and assessment of validity. J. Clin. Virol. 2019, 118, 28–35.
Davidson, J.L.; Wang, J.; Maruthamuthu, M.K.; Dextre, A.; Pascual-Garrigos, A.; Mohan, S.; Putikam, S.V.S.; Osman, F.O.I.; McChesney, D.; Seville, J.; et al. A paper-based colorimetric molecular test for SARS-CoV-2 in saliva. Biosens. Bioelectron. X 2021, 9, 100076.
Tompson, D.; Lei, Y. Recent progress in RT-LAMP enabled COVID-19 detection. Sens. Actuators Rep. 2020, 2, 100017. https://doi.org/10.1016/j.snr.2020.100017.
Kost, G.J. The Impact of Increasing Disease Prevalence, False Omissions, and Diagnostic Uncertainty on Coronavirus Disease 2019 (COVID-19) Test Performance. Arch. Pathol. Lab. Med. 2021, 145, 797–813.